Search by Drug Name or NDC
NDC 58468-0040-01 Fabrazyme 5 mg/mL Details
Fabrazyme 5 mg/mL
Fabrazyme is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genzyme Corporation. The primary component is AGALSIDASE BETA.
Product Information
NDC | 58468-0040 |
---|---|
Product ID | 58468-0040_3a3c1bad-6f7f-4300-8aa4-b4cfe8d0fc57 |
Associated GPIs | 30903610102120 |
GCN Sequence Number | 051658 |
GCN Sequence Number Description | agalsidase beta VIAL 35 MG INTRAVEN |
HIC3 | Z1H |
HIC3 Description | METABOLIC DISEASE ENZYME REPLACEMENT, FABRY'S DX |
GCN | 18997 |
HICL Sequence Number | 024861 |
HICL Sequence Number Description | AGALSIDASE BETA |
Brand/Generic | Brand |
Proprietary Name | Fabrazyme |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | AGALSIDASE BETA |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/mL |
Substance Name | AGALSIDASE BETA |
Labeler Name | Genzyme Corporation |
Pharmaceutical Class | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC], alpha-Glucosidases [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103979 |
Listing Certified Through | 2024-12-31 |
Package
NDC 58468-0040-01 (58468004001)
NDC Package Code | 58468-0040-1 |
---|---|
Billing NDC | 58468004001 |
Package | 1 VIAL, GLASS in 1 CARTON (58468-0040-1) / 7 mL in 1 VIAL, GLASS |
Marketing Start Date | 2008-12-17 |
NDC Exclude Flag | N |
Pricing Information | N/A |